ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Surescripts’ Tara Dragert Appointed to NCPDP Foundation Board to Collaborate and Support Research That Improves Data Sharing

Tara Dragert, Chief Product Officer of Surescripts®, the nation’s leading health information network, was recently appointed to serve on the board of trustees for the NCPDP Foundation during NCPDP's Annual Technology & Business Conference in Scottsdale, AZ.

“It is an honor to join the NCPDP Foundation’s board of trustees. With challenges facing nearly every part of healthcare, we are at a truly pivotal moment where collaboration and innovation can meaningfully improve the healthcare journey for patients and clinicians across the country,” said Dragert.

As a 2023‒2024 Designated Subcommittee Member, Dragert will support the NCPDP Foundation mission with a focus on approving grants that support the use of standards to make the electronic exchange of healthcare information more accurate, complete and timely. The NCPDP Foundation collaborates with organizations and individuals to support research initiatives that improve data sharing throughout the healthcare ecosystem, removing obstacles to quality care for patients.

"I’m especially excited to see NCPDP continue supporting and enabling greater care team collaboration, in particular, ensuring pharmacists can practice at the top of their training and education to maintain access to care for patients, no matter where they live,” added Dragert. “It’s also an opportunity to continue advancing health intelligence sharing at scale, creating efficiencies across healthcare while also supporting better informed, safer and less costly care for patients.”

As their essential role in the COVID-19 response made clear, pharmacists are well positioned to fill some gaps in care—if they can get the tools, information and support they need. In fact, nine in 10 prescribers and virtually all pharmacists surveyed in 2023 supported a shift toward team-based care. Both groups ranked better patient outcomes as the top benefit of pharmacists taking on more patient care responsibilities.

Dragert joined Surescripts in 2010 and today serves as Chief Product Officer. In this role, she leads teams who are developing innovative technologies to better serve patients and the clinicians who are entrusted with their care. Dragert has spent her career in healthcare technology serving the payer, provider and network industries. She has a reputation for peeling apart the layers of problems and opportunities in healthcare, identifying technology solutions, and continuously driving improvement and change.

About Surescripts Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us on LinkedIn.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.